Situation: CMS has formally announced the participant roster for its new ACCESS Model, marking a pivotal VBC policy moment under the Trump administration. Over 150 organizations—including large health systems, digital health firms, and ACOs—were accepted to pilot chronic care management innovations targeting obesity, diabetes, musculoskeletal disorders, and depression within Original Medicare. Healthcare Dive and Healthcare IT News both confirm these organizations will receive set payments for outcome-based chronic disease management. As this news broke, the [AHA] backed federal legislation to waive patient cost-sharing for chronic care services, signaling growing momentum to reduce direct financial barriers. Meanwhile, Zynix AI and PBACO are scaling AI-driven patient outreach and workflow automation within their VBC networks, and MedPAC released an analysis refuting claims that Medicare Advantage growth is compressing home health margins (Home Health Care News).

Background: This surge of policy, operational, and tech announcements comes as Healthcare Costs & Affordability, Policy & Regulatory Changes, and VBC Operations & Efficiency dominate the national VBC agenda. The ACCESS Model is the most ambitious CMMI program launched under the Trump/Oz leadership to date, explicitly linking technology, reimbursement, and outcomes for high-complexity chronic populations. Acceptance of both traditional providers and digital-first entrants deepens Medicare’s multi-pronged approach to transformation. As out-of-pocket costs remain a flashpoint, the push for cost-sharing waivers on chronic care management would fill in vital gaps left by new payment models. Concurrently, automation and AI partnerships like Zynix/PBACO hint at a maturing ecosystem prioritizing data-driven, scalable solutions across risk-bearing entities. MedPAC’s findings on MA/home health margins serve to calm fears about cross-segment cannibalization and underscore the need for nuanced, data-informed policy evaluation.

Assessment: The ACCESS Model’s full launch and its diverse applicant pool constitute a watershed: CMS is operationalizing Medicare VBC at previously unmatched scale, with explicit faith in both provider and health tech innovation. Reimbursement is becoming more tightly coupled to measurable outcomes—and, critically, to the integration of technology platforms. Yet immediate questions loom regarding the sufficiency of these payments STAT, particularly for digital firms with high user acquisition and infrastructure costs. The AHA’s legislative advocacy for cost-sharing relief signals frontline concern that current reforms are not addressing affordability at the patient level—a potential Achilles’ heel for broad adoption. AI-driven operational improvements, such as those by Zynix and PBACO, show promise in closing efficiency and engagement gaps, but also raise issues of deployment complexity and workflow disruption. MedPAC data, meanwhile, reinforce that secondary effects of MA growth may not be as dire for other VBC sectors as previously assumed, suggesting a more stable path for multi-segment providers. Overall, this moment is defined by a collision of scaling ambition, payment model uncertainty, and an intensifying demand for solutions that reach both organizational and patient-level ROI.